BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Up 159.2% in February

BiomX Inc. (NYSEAMERICAN:PHGE) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 25,400 shares, a growth of 159.2% from the February 13th total of 9,800 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 89,200 shares, the short-interest ratio is presently 0.3 days.

BiomX Price Performance

Shares of NYSEAMERICAN PHGE traded up $0.03 during midday trading on Thursday, hitting $0.60. 63,324 shares of the company traded hands, compared to its average volume of 81,726. BiomX has a 12-month low of $0.48 and a 12-month high of $4.99. The stock has a market capitalization of $10.96 million, a P/E ratio of -0.19 and a beta of 1.27.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and issued a $2.00 price objective on shares of BiomX in a report on Wednesday, January 8th.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).